Clincosm LogoSign in Get a demo

SARS-CoV-2

Showing 51 - 75 of 246
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 COVID-19 Antigen Self-Test (CoviDx™)

Terminated
  • SARS-CoV-2
  • Covid19
  • CoviDx™ Covid-19 Antigen Self-Test
  • Tampa, Florida
    PAS Research
Nov 11, 2022

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
Has Results
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

Asymptomatic SARS-CoV-2 Detection in Children

Completed
  • Covid19
  • SARS-CoV-2
    • Birmingham, Alabama
    • +4 more
    Nov 1, 2022

    SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 variant mRNA vaccine low dose
    • SARS-CoV-2 variant mRNA vaccine high dose
    • (no location specified)
    Oct 30, 2022

    d Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

    Completed
    • SARS-CoV-2
    • Enhanced Preservation Media (EPM-IX)
    • Chicago, Illinois
      UroPartners Urology Group
    Oct 14, 2022

    Determine Antibody Levels After Receiving COVID-19 Boosters of

    Completed
    • SARS-CoV-2
      • San Mateo, California
        Evidation Health
      Oct 12, 2022

      SARS-CoV-2 Trial in Canada, United States (mRNA-1273, Placebo)

      Recruiting
      • SARS-CoV-2
      • mRNA-1273
      • +2 more
      • Birmingham, Alabama
      • +89 more
      Oct 7, 2022

      SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

      Active, not recruiting
      • SARS-CoV-2
      • Influenza
      • mRNA-1073
      • +3 more
      • Hollywood, Florida
      • +13 more
      Oct 5, 2022

      SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1283.211, mRNA-1273)

      Active, not recruiting
      • SARS-CoV-2
      • mRNA-1283
      • +3 more
      • Phoenix, Arizona
      • +16 more
      Sep 22, 2022

      SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)

      Active, not recruiting
      • SARS-CoV-2
      • mRNA-1283
      • +2 more
      • Chandler, Arizona
      • +4 more
      Sep 22, 2022

      SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

      Completed
      Has Results
      • SARS-CoV-2
      • COVID-19
      • ACE inhibitor, angiotensin receptor blocker
      • Innsbruck, Tyrol, Austria
      • +30 more
      Aug 18, 2022

      Effect of COVID-19 on Platelet Aggregation

      Recruiting
      • COVID-19
      • SARS-CoV-2
      • venipuncture in peripheral vein
      • Sao Paulo, Brazil
      • +1 more
      Sep 12, 2022

      SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

      Active, not recruiting
      • SARS-CoV-2
      • mRNA-1273
      • Mesa, Arizona
      • +14 more
      Aug 31, 2022

      COVID-19, SARS-CoV-2, Furin Trial in India, Ukraine, United States

      Recruiting
      • COVID-19
      • +4 more
        • Jacksonville, Florida
        • +8 more
        Aug 11, 2022

        SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,

        Not yet recruiting
        • SARS-CoV-2
        • +2 more
        • one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
        • +3 more
        • Wuhan, Hubei, China
          Zhongnan Hospital of Wuhan University
        Aug 9, 2022

        COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)

        Terminated
        Has Results
        • COVID-19
        • SARS-CoV-2
        • Ascorbic Acid
        • +4 more
        • Chicago, Illinois
        • +5 more
        Jul 12, 2022

        SARS-CoV-2 Trial in Leuven (Sampling of tissue)

        Recruiting
        • SARS-CoV-2
        • Sampling of tissue
        • Leuven, Vlaams-Brabant, Belgium
          UZ Leuven
        Aug 3, 2022

        SARS-CoV-2, Covid-19, Coronavirus Trial in Miami (Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test)

        Withdrawn
        • SARS-CoV-2
        • +2 more
        • Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test
        • Miami, Florida
          D&H National Research Centers INC
        Aug 3, 2022

        SARS-CoV-2 Trial in Newark (DUR-928, Placebo)

        Terminated
        Has Results
        • SARS-CoV-2
        • Newark, New Jersey
          Site 03
        Jul 12, 2022

        SARS-CoV-2 Trial in United States (mRNA-1273.214)

        Recruiting
        • SARS-CoV-2
        • mRNA-1273.214
        • Montebello, California
        • +6 more
        Jul 28, 2022

        SARS-CoV-2 Trial in Australia, Philippines, United States (CV0501 (3 µg), CV0501 (6 µg), CV0501 (12 µg))

        Not yet recruiting
        • SARS-CoV-2
        • CV0501 (3 μg)
        • +8 more
        • Sacramento, California
        • +19 more
        Jul 27, 2022

        SARS-CoV-2 Trial in Buon Ma Thuot City (S-268019-b, Placebo)

        Active, not recruiting
        • SARS-CoV-2
        • Buon Ma Thuot City, Dak Lak, Vietnam
          Buon Ma Thuot City Medical Center
        Jul 26, 2022

        Patients With Acute Leukemia Infected by COVID-19

        Completed
        • Acute Myeloblastic Leukemia
        • +2 more
          • Amiens, France
          • +26 more
          Jul 26, 2022

          SARS-CoV-2 Trial in Worldwide (Covigenix VAX-001 , Covigenix VAX-001)

          Recruiting
          • SARS-CoV-2
          • Covigenix VAX-001 placebo
          • Covigenix VAX-001
          • Ouagadougou, Burkina Faso
          • +4 more
          Jul 23, 2022

          SARS-CoV-2 Trial in United States (CV2CoV (2 µg), CV2CoV (4 µg), CV2CoV (8 µg))

          Recruiting
          • SARS-CoV-2
          • CV2CoV (2 µg)
          • +5 more
          • La Mesa, California
          • +13 more
          Jul 21, 2022